Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients

Romain Banchereau, Seunghee Hong, Brandi Cantarel, Nicole Baldwin, Jeanine Baisch, Michelle Edens, Alma Martina Cepika, Peter Acs, Jacob Turner, Esperanza Anguiano, Parvathi Vinod, Shaheen Kahn, Gerlinde Obermoser, Derek Blankenship, Edward Wakeland, Lorien Nassi, Alisa Gotte, Marilynn Punaro, Yong Jun Liu, Jacques Banchereau & 3 others Jose Rossello-Urgell, Tracey Wright, Virginia Pascual

Research output: Contribution to journalArticle

130 Citations (Scopus)

Abstract

Summary Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of tolerance to nucleic acids and highly diverse clinical manifestations. To assess its molecular heterogeneity, we longitudinally profiled the blood transcriptome of 158 pediatric patients. Using mixed models accounting for repeated measurements, demographics, treatment, disease activity (DA), and nephritis class, we confirmed a prevalent IFN signature and identified a plasmablast signature as the most robust biomarker of DA. We detected gradual enrichment of neutrophil transcripts during progression to active nephritis and distinct signatures in response to treatment in different nephritis subclasses. Importantly, personalized immunomonitoring uncovered individual correlates of disease activity that enabled patient stratification into seven groups, supported by patient genotypes. Our study uncovers the molecular heterogeneity of SLE and provides an explanation for the failure of clinical trials. This approach may improve trial design and implementation of tailored therapies in genetically and clinically complex autoimmune diseases.

Original languageEnglish (US)
Pages (from-to)551-565
Number of pages15
JournalCell
Volume165
Issue number3
DOIs
StatePublished - Apr 21 2016

Fingerprint

Nephritis
Systemic Lupus Erythematosus
Autoimmune Diseases
Transcriptome
Nucleic Acids
Neutrophils
Therapeutics
Biomarkers
Genotype
Pediatrics
Demography
Clinical Trials
Blood

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Banchereau, R., Hong, S., Cantarel, B., Baldwin, N., Baisch, J., Edens, M., ... Pascual, V. (2016). Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients. Cell, 165(3), 551-565. https://doi.org/10.1016/j.cell.2016.03.008

Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients. / Banchereau, Romain; Hong, Seunghee; Cantarel, Brandi; Baldwin, Nicole; Baisch, Jeanine; Edens, Michelle; Cepika, Alma Martina; Acs, Peter; Turner, Jacob; Anguiano, Esperanza; Vinod, Parvathi; Kahn, Shaheen; Obermoser, Gerlinde; Blankenship, Derek; Wakeland, Edward; Nassi, Lorien; Gotte, Alisa; Punaro, Marilynn; Liu, Yong Jun; Banchereau, Jacques; Rossello-Urgell, Jose; Wright, Tracey; Pascual, Virginia.

In: Cell, Vol. 165, No. 3, 21.04.2016, p. 551-565.

Research output: Contribution to journalArticle

Banchereau, R, Hong, S, Cantarel, B, Baldwin, N, Baisch, J, Edens, M, Cepika, AM, Acs, P, Turner, J, Anguiano, E, Vinod, P, Kahn, S, Obermoser, G, Blankenship, D, Wakeland, E, Nassi, L, Gotte, A, Punaro, M, Liu, YJ, Banchereau, J, Rossello-Urgell, J, Wright, T & Pascual, V 2016, 'Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients', Cell, vol. 165, no. 3, pp. 551-565. https://doi.org/10.1016/j.cell.2016.03.008
Banchereau, Romain ; Hong, Seunghee ; Cantarel, Brandi ; Baldwin, Nicole ; Baisch, Jeanine ; Edens, Michelle ; Cepika, Alma Martina ; Acs, Peter ; Turner, Jacob ; Anguiano, Esperanza ; Vinod, Parvathi ; Kahn, Shaheen ; Obermoser, Gerlinde ; Blankenship, Derek ; Wakeland, Edward ; Nassi, Lorien ; Gotte, Alisa ; Punaro, Marilynn ; Liu, Yong Jun ; Banchereau, Jacques ; Rossello-Urgell, Jose ; Wright, Tracey ; Pascual, Virginia. / Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients. In: Cell. 2016 ; Vol. 165, No. 3. pp. 551-565.
@article{8d640420a32f4b448d75631c3420d53c,
title = "Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients",
abstract = "Summary Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of tolerance to nucleic acids and highly diverse clinical manifestations. To assess its molecular heterogeneity, we longitudinally profiled the blood transcriptome of 158 pediatric patients. Using mixed models accounting for repeated measurements, demographics, treatment, disease activity (DA), and nephritis class, we confirmed a prevalent IFN signature and identified a plasmablast signature as the most robust biomarker of DA. We detected gradual enrichment of neutrophil transcripts during progression to active nephritis and distinct signatures in response to treatment in different nephritis subclasses. Importantly, personalized immunomonitoring uncovered individual correlates of disease activity that enabled patient stratification into seven groups, supported by patient genotypes. Our study uncovers the molecular heterogeneity of SLE and provides an explanation for the failure of clinical trials. This approach may improve trial design and implementation of tailored therapies in genetically and clinically complex autoimmune diseases.",
author = "Romain Banchereau and Seunghee Hong and Brandi Cantarel and Nicole Baldwin and Jeanine Baisch and Michelle Edens and Cepika, {Alma Martina} and Peter Acs and Jacob Turner and Esperanza Anguiano and Parvathi Vinod and Shaheen Kahn and Gerlinde Obermoser and Derek Blankenship and Edward Wakeland and Lorien Nassi and Alisa Gotte and Marilynn Punaro and Liu, {Yong Jun} and Jacques Banchereau and Jose Rossello-Urgell and Tracey Wright and Virginia Pascual",
year = "2016",
month = "4",
day = "21",
doi = "10.1016/j.cell.2016.03.008",
language = "English (US)",
volume = "165",
pages = "551--565",
journal = "Cell",
issn = "0092-8674",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients

AU - Banchereau, Romain

AU - Hong, Seunghee

AU - Cantarel, Brandi

AU - Baldwin, Nicole

AU - Baisch, Jeanine

AU - Edens, Michelle

AU - Cepika, Alma Martina

AU - Acs, Peter

AU - Turner, Jacob

AU - Anguiano, Esperanza

AU - Vinod, Parvathi

AU - Kahn, Shaheen

AU - Obermoser, Gerlinde

AU - Blankenship, Derek

AU - Wakeland, Edward

AU - Nassi, Lorien

AU - Gotte, Alisa

AU - Punaro, Marilynn

AU - Liu, Yong Jun

AU - Banchereau, Jacques

AU - Rossello-Urgell, Jose

AU - Wright, Tracey

AU - Pascual, Virginia

PY - 2016/4/21

Y1 - 2016/4/21

N2 - Summary Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of tolerance to nucleic acids and highly diverse clinical manifestations. To assess its molecular heterogeneity, we longitudinally profiled the blood transcriptome of 158 pediatric patients. Using mixed models accounting for repeated measurements, demographics, treatment, disease activity (DA), and nephritis class, we confirmed a prevalent IFN signature and identified a plasmablast signature as the most robust biomarker of DA. We detected gradual enrichment of neutrophil transcripts during progression to active nephritis and distinct signatures in response to treatment in different nephritis subclasses. Importantly, personalized immunomonitoring uncovered individual correlates of disease activity that enabled patient stratification into seven groups, supported by patient genotypes. Our study uncovers the molecular heterogeneity of SLE and provides an explanation for the failure of clinical trials. This approach may improve trial design and implementation of tailored therapies in genetically and clinically complex autoimmune diseases.

AB - Summary Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of tolerance to nucleic acids and highly diverse clinical manifestations. To assess its molecular heterogeneity, we longitudinally profiled the blood transcriptome of 158 pediatric patients. Using mixed models accounting for repeated measurements, demographics, treatment, disease activity (DA), and nephritis class, we confirmed a prevalent IFN signature and identified a plasmablast signature as the most robust biomarker of DA. We detected gradual enrichment of neutrophil transcripts during progression to active nephritis and distinct signatures in response to treatment in different nephritis subclasses. Importantly, personalized immunomonitoring uncovered individual correlates of disease activity that enabled patient stratification into seven groups, supported by patient genotypes. Our study uncovers the molecular heterogeneity of SLE and provides an explanation for the failure of clinical trials. This approach may improve trial design and implementation of tailored therapies in genetically and clinically complex autoimmune diseases.

UR - http://www.scopus.com/inward/record.url?scp=84962128086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962128086&partnerID=8YFLogxK

U2 - 10.1016/j.cell.2016.03.008

DO - 10.1016/j.cell.2016.03.008

M3 - Article

VL - 165

SP - 551

EP - 565

JO - Cell

JF - Cell

SN - 0092-8674

IS - 3

ER -